Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing Matters: Extended vs. Brief Pre-Spinal Ondansetron for Maternal Hypotension Prevention in Cesarean Delivery
TCTR20250130001Phase 3Recruiting
- Sponsor
- N/A
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ondansetron in hypotension, sponsored by N/A. Started Oct 2024; status: recruiting.
02
Drugs
ondansetron
03
Conditions
hypotension
Beyond the preview
Go deeper on TCTR20250130001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250130001.